CRISPR Therapeutics
CRSP
#3011
Rank
A$8.02 B
Marketcap
A$82.97
Share price
2.37%
Change (1 day)
-0.60%
Change (1 year)

Financial Statements

Thumbnail CRISPR Therapeutics Financial Statement 2025

Financial Statement 2025

Language: English

View Financial Statement
Thumbnail CRISPR Therapeutics Financial Statement 2024

Financial Statement 2024

Language: English

View Financial Statement
Thumbnail CRISPR Therapeutics Financial Statement 2023

Financial Statement 2023

Language: English

View Financial Statement
Thumbnail CRISPR Therapeutics Financial Statement 2022

Financial Statement 2022

Language: English

View Financial Statement
Thumbnail CRISPR Therapeutics Financial Statement 2021

Financial Statement 2021

Language: English

View Financial Statement